Oxygen-guided red blood cell transfusion trial
Part of Blood & lymphatic clinical trials.
This trial tests whether using a measure of oxygen in your body can guide doctors on when to give you a blood transfusion. It may help avoid unnecessary transfusions while ensuring you get enough oxygen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a hemoglobin level of 9.0 grams per deciliter or lower, confirmed by a blood test.
- You have both an arterial line and a central venous line placed, with the tip of the central line in the correct position to measure oxygen levels in your blood.
- You are 18 years or older.
- You are not pregnant.
- You do not have active bleeding, a blood cancer, sickle cell disease, or a bleeding disorder.
- You do not have moderate to severe kidney disease or acute kidney injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized plan for when to give blood transfusions works better than the usual approach in people having heart surgery with a heart-lung machine. The goal is to find a safer and more effective way to manage transfusions during recovery.
This trial tests whether giving blood in a personalized way, instead of a standard approach, is better for people on a heart-lung bypass machine (VA-ECMO) for heart-related shock. It may help find a safer blood transfusion strategy while you are critically ill.
This study looks at whether giving red blood cell transfusions in a specific way is practical and safe for people receiving ECMO (a heart-lung support machine). It’s mainly a feasibility study, meaning the goal is to see if the plan can be carried out smoothly and safely.
This trial tests whether giving more or fewer red blood cell transfusions is better for adult patients on ECMO (a machine that helps your heart and lungs work). The goal is to find the best transfusion approach to improve outcomes.
This trial tests if using a specific oxygen measurement (ScvO2) helps guide red blood cell transfusions more safely in ICU patients with moderate anemia. It aims to avoid unnecessary transfusions while ensuring enough oxygen reaches your tissues.
This trial is testing whether a higher or lower threshold for red blood cell transfusions is better for people on ECMO (a heart-lung machine). It aims to find the safest way to manage transfusions during ECMO treatment.
Hear when a new Blood Transfusion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.